Neogen Corporation (NEOG) Income Statement

The negative growth trend appears to be stabilizing, as the most recent quarter's decline is the smallest in the sequence, but there is no evidence of a return to expansion. The flat revenue trajectory suggests that the combined entity is struggling to retain customers or gain traction, possibly due to disruption from the merger. Investors should monitor whether management's guidance for FY27 as a transition year translates into tangible top-line stabilization.

The sharp recovery in gross margin suggests that the cost distortions from the merger are temporary, but the current level remains below the 50.5% achieved in 2024Q3, implying that the combined product mix may be less favorable. The structural gross margin is likely to be pressured by the lower-margin 3M Food Safety products, and management's ability to shift toward higher-margin consumables and genomics will be critical for long-term profitability.

The positive operating income is a step in the right direction, but the margin is still thin, indicating that SG&A expenses remain elevated relative to revenue. The company has not yet demonstrated that it can scale operating income faster than gross profit, as SG&A has remained relatively flat around $100M per quarter. Achieving meaningful operating leverage will likely require cost synergies from the merger to materialize, which is not yet evident in the data.

The lack of SG&A reduction despite revenue contraction suggests that the company has not yet realized cost synergies from the merger, or that it is investing in integration and retention efforts. The high fixed-cost base is a concern, as it limits operating leverage and puts pressure on margins. Management's commentary about 'disciplined execution' in FY27 may indicate a focus on cost control, but the data shows no evidence of improvement yet.

This quarter represents the culmination of the 3M Food Safety merger's accounting distortions, with a net margin of -271.5% (calculated from data). The subsequent quarters show a gradual recovery, suggesting that the worst of the charges are behind the company. However, the lasting impact is a depressed earnings base and a need to rebuild investor confidence, which may take several quarters of clean results.